补充因子B (CFB) 通过降低Ras/MAPK信号通路的调节来抑制肺腺癌的恶性进展
ChengLu He1, Xiao Wang1, Bo Jiang1
1Department of Clinical Laboratory, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, China; Yunnan Key Laboratory of Laboratory Medicine, Kunming, 650032, Yunnan, China; Yunnan Province Clinical Research Center for Laboratory Medicine, Kunming, 650032, China.
Archives of biochemistry and biophysics
|August 22, 2024
概括
补充因子B (CFB) 通过抑制Ras/MAPK通路来抑制肺腺癌 (LUAC) 的进展. 这一发现表明CFB是LUAC的潜在治疗点.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 全球肺腺癌 (LUAC) 发病率正在上升.
- 补充因子B (CFB) 在LUAC瘤发生中的作用在很大程度上是未知的.
- 之前的研究结果表明,在LUAC临床样本中,CFB下调.
研究的目的:
- 调查在LUAC中CFB的功能和分子机制.
- 探索CFB作为LUAC的潜在生物标志物和治疗点.
主要方法:
- 在体外细胞增殖,迁移,细胞亡和细胞循环的测试.
- 在小鼠模型中体内瘤生长和Ki67表达分析.
- 西部斑点分析以评估Ras/MAPK信号通路的激活.
- 对Ras/MAPK通路的药理学操纵.
主要成果:
- 击败CFB增加了LUAC细胞的增殖和迁移,同时抑制了细胞亡和细胞循环停止.
- 在体外,CFB过度表达抑制了LUAC恶性进展,并在体内抑制了瘤生长.
- CFB对Ras/MAPK信号通路进行了负调节.
- 拉斯/MAPK通路激活剂逆转了CFB对LUAC进展的抑制作用.
结论:
- 在LUAC中,CFB作为瘤抑制剂起作用.
- 通过抑制Ras/MAPK通路,CFB可以抑制LUAC瘤的发生.
- CFB代表了LUAC的潜在诊断生物标志物和治疗标.
相关概念视频
MAPK Signaling Cascades
5.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K


